Abstract
As biologic treatments for a variety of medical conditions become more commonly utilized, the utilization of autologous tissues for orthopaedic conditions has increased. In particular, human adipose derived mesenchymal stem/stromal cell (ADSC) therapies have become increasingly popular over the past decade. The ability to utilize a patient's own homologous tissue, with minimal manipulation, and improve the biologic environment of the diseased tissue, has the potential to dramatically improve the quality of life for hundreds of thousands of patients. ADSCs are readily harvested from several easily accessible patient sites, including the subcutaneous tissue via simple lipoaspiration, as well as the infrapatellar fat pad via standard arthroscopic techniques. Moving forward, it remains paramount to continue to study ADSCs as a biologic therapeutic, better understand how to safely process this tissue once harvested, and determine which patient/pathology is best suited for injection or implantation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
